← Leaderboards
Steven A. Rosenzweig
Medical University Of South Carolina
$3,554,090
Attributed
$3,554,090
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $529.9K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,554,090 · 4
By mechanism
R01$2,965,502 · 2
R41$474,531 · 1
P30$114,057 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Jeremy Yongxin Yu$1,968,185
- Robin C Muise-Helmericks$2,253,220
- Timothy J Lyons$5,303,277
- Chenthamarakshan Vasu$10,772,753
- Zsolt Ablonczy$1,874,385
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureBinding SitesMolecular DynamicsSouth CarolinaProtein Structure FunctionSite Directed MutagenesisGrowth Factor ReceptorsIntermolecular InteractionMass SpectrometryMolecular ChaperonesPeptide LibraryPlayAffinity LabelingRecombinant ProteinsChemical ModelsBinding ProteinsInsulinlike Growth FactorBiotinLaboratory RabbitMalignant NeoplasmsCarcinogenesis InhibitorDrug Design /Synthesis /ProductionEndothelial CellsMediating
Grant awards (19)
Shared Resource Management$58,688
P30 · FY2025 · CA · contact PI
Non-toxic CNS drug delivery across the BBB in Alzheimer's and other dementias$474,531
R41 · FY2024 · AG · contact PI
Shared Resource Management$55,369
P30 · FY2024 · CA · contact PI
Receptor Crosstalk in HNSCC Metastatic Progression$224,569
R01 · FY2016 · CA · contact PI
Receptor Crosstalk in HNSCC Metastatic Progression$224,569
R01 · FY2015 · CA · contact PI
Receptor Crosstalk in HNSCC Metastatic Progression$217,832
R01 · FY2014 · CA · contact PI
Receptor Crosstalk in HNSCC Metastatic Progression$211,095
R01 · FY2013 · CA · contact PI
Receptor Crosstalk in HNSCC Metastatic Progression$224,569
R01 · FY2012 · CA · contact PI
Receptor Crosstalk in HNSCC Metastatic Progression$224,569
R01 · FY2010 · CA · contact PI
Receptor Crosstalk in HNSCC Metastatic Progression$224,569
R01 · FY2009 · CA · contact PI
INHIBITION OF IGF MEDIATED TUMORIGENESIS$257,400
R01 · FY2004 · CA
INHIBITION OF IGF MEDIATED TUMORIGENESIS$34,425
R01 · FY2004 · CA
INHIBITION OF IGF MEDIATED TUMORIGENESIS$257,400
R01 · FY2003 · CA
INHIBITION OF IGF MEDIATED TUMORIGENESIS$33,548
R01 · FY2003 · CA
INHIBITION OF IGF MEDIATED TUMORIGENESIS$257,400
R01 · FY2002 · CA
INHIBITION OF IGF MEDIATED TUMORIGENESIS$32,695
R01 · FY2002 · CA
INHIBITION OF IGF MEDIATED TUMORIGENESIS$257,400
R01 · FY2001 · CA
INHIBITION OF IGF MEDIATED TUMORIGENESIS$31,867
R01 · FY2001 · CA
INHIBITION OF IGF MEDIATED TUMORIGENESIS$251,595
R01 · FY2000 · CA